✦ LIBER ✦

Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine

✍ Scribed by M. Viganò; P. Lampertico; F. Facchetti; G. Lunghi; M. Colombo

Book ID: 108886202
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 45 KB
Volume: 15
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2008.01047.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of adefovir dipivoxi

Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily

✍ Christophe Hézode; Stéphane Chevaliez; Magali Bouvier-Alias; Françoise Roudot-Th 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 125 KB

A Prospective Randomized Trial of Switch

A Prospective Randomized Trial of Switching to Telbivudine Plus Adefovir in HBeAg-positive Lamivudine-resistant Chronic Hepatitis B Patients Who Have Suboptimal Response to Lamivudine Plus Adefovir

✍ Park, Hana; Park, Jun Yong; Kim, Seung Up; Kim, Do Young; Han, Kwang-Hyub; Chon, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 43 KB

515 Non-response and resistance to adefo

515 Non-response and resistance to adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ A. Valdes; M. Buti; R. Jardi; E. Rodriguez-Frias; M. Schaner; R. Esteban; J. Gua 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Efficacy of entecavir in patients with c

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

✍ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/

11 Adefovir dipivoxil 10 MG (ADV) for th

11 Adefovir dipivoxil 10 MG (ADV) for the treatment of chronic hepatitis B in patients pre-liver transplantation with lamivudine-resistant patients

✍ Eurgen Schiff; Ching-Lung Lai; Stefanos Hadziyannis; Peter Neuhaus; Norah Terrau 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Combination of Lamivudine and adefovir t

Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy

✍ L.-C. Wang; E.-Q. Chen; J. Cao; L. Liu; J.-R. Wang; B.-J. Lei; H. Tang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB